XML 60 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Restructuring (Tables)
9 Months Ended
Oct. 01, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve
The following table summarizes the restructuring expenses for 2023:
(Pre-tax Dollars in Millions)Fiscal Third Quarter EndedFiscal Nine Months Ended
Innovative Medicine Segment (1)
$149 424 
MedTech Segment (2)
235 235 
Total Programs$384 659 
(1) Included in Restructuring on the Consolidated Statement of Earnings
(2) Included $9 million in the Restructuring and $226 million in Cost of products sold on the Consolidated Statement of Earnings